Sage Therapeutics Statistics
Total Valuation
SAGE has a market cap or net worth of $704.13 million. The enterprise value is -$12.41 million.
| Market Cap | 704.13M |
| Enterprise Value | -12.41M |
Important Dates
The last earnings date was Thursday, April 25, 2024, before market open.
| Earnings Date | Apr 25, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SAGE has 60.18 million shares outstanding. The number of shares has increased by 0.77% in one year.
| Shares Outstanding | 60.18M |
| Shares Change (YoY) | +0.77% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 12.47% |
| Owned by Institutions (%) | 99.59% |
| Float | 47.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.73 |
| Forward PS | 12.17 |
| PB Ratio | 1.00 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.22, with a Debt / Equity ratio of 0.00.
| Current Ratio | 12.22 |
| Quick Ratio | 11.82 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -60.90% and return on invested capital (ROIC) is -76.44%.
| Return on Equity (ROE) | -60.90% |
| Return on Assets (ROA) | -54.70% |
| Return on Capital (ROIC) | -76.44% |
| Revenue Per Employee | $186,990 |
| Profits Per Employee | -$1.03M |
| Employee Count | 487 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.65% in the last 52 weeks. The beta is 0.91, so SAGE's price volatility has been similar to the market average.
| Beta (1Y) | 0.91 |
| 52-Week Price Change | -77.65% |
| 50-Day Moving Average | 15.83 |
| 200-Day Moving Average | 20.08 |
| Relative Strength Index (RSI) | 31.84 |
| Average Volume (30 Days) | 1,012,407 |
Short Selling Information
The latest short interest is 8.15 million, so 13.55% of the outstanding shares have been sold short.
| Short Interest | 8.15M |
| Short Previous Month | 9.31M |
| Short % of Shares Out | 13.55% |
| Short % of Float | 17.16% |
| Short Ratio (days to cover) | 6.73 |
Income Statement
In the last 12 months, SAGE had revenue of $91.06 million and -$503.14 million in losses. Loss per share was -$8.39.
| Revenue | 91.06M |
| Gross Profit | 87.87M |
| Operating Income | -542.06M |
| Pretax Income | -503.14M |
| Net Income | -503.14M |
| EBITDA | -501.74M |
| EBIT | -503.14M |
| Loss Per Share | -$8.39 |
Balance Sheet
The company has $719.85 million in cash and $3.31 million in debt, giving a net cash position of $716.54 million or $11.91 per share.
| Cash & Cash Equivalents | 719.85M |
| Total Debt | 3.31M |
| Net Cash | 716.54M |
| Net Cash Per Share | $11.91 |
| Equity / Book Value | 705.80M |
| Book Value Per Share | 11.73 |
| Working Capital | 693.64M |
Cash Flow
In the last 12 months, operating cash flow was -$424.74 million and capital expenditures -$328,000, giving a free cash flow of -$425.06 million.
| Operating Cash Flow | -424.74M |
| Capital Expenditures | -328,000 |
| Free Cash Flow | -425.06M |
| FCF Per Share | -$7.07 |
Margins
Gross margin is 96.49%, with operating and profit margins of -595.25% and -552.52%.
| Gross Margin | 96.49% |
| Operating Margin | -595.25% |
| Pretax Margin | -552.52% |
| Profit Margin | -552.52% |
| EBITDA Margin | -550.97% |
| EBIT Margin | -552.52% |
| FCF Margin | -466.77% |
Dividends & Yields
SAGE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.77% |
| Shareholder Yield | -0.77% |
| Earnings Yield | -71.46% |
| FCF Yield | -60.37% |
Analyst Forecast
The average price target for SAGE is $19.56, which is 67.18% higher than the current price. The consensus rating is "Hold".
| Price Target | $19.56 |
| Price Target Difference | 67.18% |
| Analyst Consensus | Hold |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 50.08% |
| EPS Growth Forecast (5Y) | -25.45% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SAGE has an Altman Z-Score of 0.99 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.99 |
| Piotroski F-Score | 3 |